The protective effect of myo-inositol on human thyrocytes

Rev Endocr Metab Disord. 2018 Dec;19(4):355-362. doi: 10.1007/s11154-018-9476-x.

Abstract

Patients affected by autoimmune thyroiditis reached positive effects on indices of thyroid autoimmunity and/or thyroidal function, after following a treatment with selenomethionine (Se) alone, or Se in combination with Myo-inositol (Myo-Ins). Our purpose was to investigate if Myo-Ins alone, or a combination of Se + Myo-Ins, is effective in protecting thyroid cells from the effects given by cytokines, or hydrogen peroxide (H2O2). We assessed the interferon (IFN)-γ-inducible protein 10 (IP-10/CXCL10) secretion by stimulating primary thyrocytes (obtained from Hashimoto's thyroiditis or from control patients) with cytokines in presence/absence of H2O2. Our results confirm: 1) the toxic effect of H2O2 in primary thyrocytes that leads to an increase of the apoptosis, to a decrease of the proliferation, and to a slight reduction of cytokines-induced CXCL10 secretion; 2) the secretion of CXCL10 chemokine induced by IFN-γ + tumor necrosis factor alpha (TNF)-α has been decreased by Myo + Ins, both in presence or absence of H2O2; 3) no effect has been shown by the treatment with Se. Therefore, a protective effect of Myo-Ins on thyroid cells has been suggested by our data, which exact mechanisms are at the basis of this effect need to be furtherly investigated.

Keywords: CXCL10; Cytokines; Hydrogen peroxide; Myo-inositol; Selenomethionine; Thyrocytes.

MeSH terms

  • Chemokine CXCL10 / metabolism*
  • Hashimoto Disease / surgery
  • Humans
  • Inositol / pharmacology*
  • Selenomethionine / pharmacology*
  • Thyroid Epithelial Cells / drug effects*
  • Thyroid Epithelial Cells / metabolism*
  • Thyroid Nodule / surgery

Substances

  • CXCL10 protein, human
  • Chemokine CXCL10
  • Inositol
  • Selenomethionine